We are very excited to welcome Cora Sternberg, MD, to the Genitourinary (GU) Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital.
Dr. Sternberg is a leading international researcher and world expert in the field of medical oncology, genitourinary (GU) cancers, and drug development. She is known for her influential work in developing novel therapies and targeted agents for the treatment of prostate, renal and bladder cancers.
In her new role, Dr. Sternberg will facilitate the continued growth and development of clinical and translational research programs in genitourinary (GU) malignancies. She will also serve as Clinical Director of the Englander Institute for Precision Medicine (EIPM), developing strategies to incorporate genomic sequencing and precision medicine throughout the Weill Cornell Medicine and NewYork-Presbyterian healthcare network, including Lower Manhattan, Brooklyn and Queens.
Visit Dr. Sternberg’s profile to learn more about her medical experience and accomplishments.
What's New in GU? 